Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Müller, Stephan ^a   Preische, Oliver ^a,b   Sohrabi, Hamid R ^c,d   Gräber, Susanne ^b,e   Jucker, Mathias ^b,e   Dietzsch, Janko ^e   Ringman, John M ^f   Martins, Ralph N ^c,d   McDade, Eric ^g   Schofield, Peter R ^h,i   Ghetti, Bernardino ^j   Rossor, Martin ^k   Graff Radford, Neill R ^l,m   Levin, Johannes ^b,n   Galasko, Douglas ^o   Quaid, Kimberly A ^p   Salloway, Stephen ^q   Xiong, Chengjie ^r   Benzinger, Tammie ^r   Buckles, Virginia ^r   Masters, Colin L ^s   Sperling, Reisa ^t   Bateman, Randall J ^r   Morris, John C ^r   Laske, Christoph ^b,e   more..

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c EDITH COWAN UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

ⁱ UNIVERSITY OF NEW SOUTH WALES   (Australia)

^j INDIANA UNIVERSITY   (United States)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l MAYO GRADUATE SCHOOL   (United States)

^m MAYO CLINIC   (United States)

ⁿ UNIVERSITY OF MUNICH   (Germany)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p Indiana University   (United States)

^q BROWN UNIVERSITY   (United States)

^r WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s UNIVERSITY OF MELBOURNE   (Australia)

^t MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BODY MASS; BODY WEIGHT LOSS; CROSS-SECTIONAL STUDY; HETEROZYGOTE; HUMAN; LONGITUDINAL STUDY; PATHOLOGY;

ALZHEIMER DISEASE; BODY MASS INDEX; CARRIER STATE; CROSS-SECTIONAL STUDIES; HUMANS; LONGITUDINAL STUDIES; WEIGHT LOSS;

EID: 85018261608     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-01327-w     Document Type: Article

References (35)

1. Garcia-Ptacek, S., Faxen-Irving, G., Cermakova, P., Eriksdotter, M. & Religa, D. Body mass index in dementia. European journal of clinical nutrition 68, 1204-1209, doi:10.1038/ejcn.2014.199 (2014).
2. Emmerzaal, T. L., Kiliaan, A. J. & Gustafson, D. R. 2003-2013: a decade of body mass index, Alzheimer's disease, and dementia. Journal of Alzheimer's disease: JAD 43, 739-755, doi:10.3233/jad-141086 (2015).
3. Chuang, Y. F. et al. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation. Molecular psychiatry, 10.1038/mp.2015.129 (2015).
4. Buchman, A. S. et al. Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897, doi:10.1212/01. wnl.0000176061.33817.90 (2005).
5. Stewart, R. et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Archives of neurology 62, 55-60, doi:10.1001/archneur.62.1.55 (2005).
6. Johnson, D. K., Wilkins, C. H. & Morris, J. C. Accelerated weight loss may precede diagnosis in Alzheimer disease. Archives of neurology 63, 1312-1317, doi:10.1001/archneur.63.9.1312 (2006).
7. Fitzpatrick, A. L. et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Archives of neurology 66, 336-342, doi:10.1001/archneurol.2008.582 (2009).
8. Hughes, T. F., Borenstein, A. R., Schofield, E., Wu, Y. & Larson, E. B. Association between late-life body mass index and dementia: The Kame Project. Neurology 72, 1741-1746, doi:10.1212/WNL.0b013e3181a60a58 (2009).
9. Morris, J. C. et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical investigation 2, 975-984, doi:10.4155/cli.12.93 (2012).
10. Moulder, K. L. et al. Dominantly Inherited Alzheimer Network: facilitating research and clinical trials. Alzheimer's research & therapy 5, 48, doi:10.1186/alzrt213 (2013).
11. Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England journal of medicine 367, 795-804, doi:10.1056/NEJMoa1202753 (2012).
12. Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414, doi:10.1212/ WNL.43.11.2412-a (1993).
13. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization technical report series 894, i-xii, 1-253 (2000).
14. Ryman, D. C. et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83, 253-260, doi:10.1212/wnl.0000000000000596 (2014).
15. R: A Language and Environment for Statistical Computing (The R Foundation for Statistical Computing, Vienna, Austria, 2011).
16. Wickham, W. ggplot2: elegant graphics for data analysis. (Springer, 2009).
17. Soto, M. E. et al. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease. Journal of Alzheimer's disease: JAD 28, 647-654, doi:10.3233/jad-2011-110713 (2012).
18. Gustafson, D. R. et al. 37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden. Journal of Alzheimer's disease: JAD 28, 163-171, doi:10.3233/jad-2011-110917 (2012).
19. Morley, J. E. Anorexia and weight loss in older persons. The journals of gerontology. Series A, Biological sciences and medical sciences 58, 131-137, doi:10.1093/gerona/58.2.M131 (2003).
20. Vidoni, E. D., Townley, R. A., Honea, R. A. & Burns, J. M. Alzheimer disease biomarkers are associated with body mass index. Neurology 77, 1913-1920, doi:10.1212/WNL.0b013e318238eec1 (2011).
21. Donini, L. M., Savina, C. & Cannella, C. Eating habits and appetite control in the elderly: the anorexia of aging. International psychogeriatrics/IPA 15, 73-87, doi:10.1017/S1041610203008779 (2003).
22. Buchman, A. S., Schneider, J. A., Wilson, R. S., Bienias, J. L. & Bennett, D. A. Body mass index in older persons is associated with Alzheimer disease pathology. Neurology 67, 1949-1954, doi:10.1212/01.wnl.0000247046.90574.0f (2006).
23. Ewers, M. et al. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiology of aging 33, 1599-1608, doi:10.1016/j.neurobiolaging.2011.05.005 (2012).
24. Bastien, M., Poirier, P., Lemieux, I. & Despres, J. P. Overview of epidemiology and contribution of obesity to cardiovascular disease. Progress in cardiovascular diseases 56, 369-381, doi:10.1016/j.pcad.2013.10.016 (2014).
25. Meneilly, G. S. & Hill, A. Alterations in glucose metabolism in patients with Alzheimer's disease. Journal of the American Geriatrics Society 41, 710-714, doi:10.1111/jgs.1993.41.issue-7 (1993).
26. Guillozet, A. L., Weintraub, S., Mash, D. C. & Mesulam, M. M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Archives of neurology 60, 729-736, doi:10.1001/archneur.60.5.729 (2003).
27. Schwartz, M. W., Woods, S. C., Porte, D. Jr., Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661-671, doi:10.1038/35007534 (2000).
28. Morgan, D. & Gordon, M. N. Amyloid, hyperactivity, and metabolism: theoretical comment on Vloeberghs et al. (2008). Behavioral neuroscience 122, 730-732, doi:10.1037/0735-7044.122.3.730 (2008).
29. Vloeberghs, E. et al. Altered ingestive behavior, weight changes, and intact olfactory sense in an APP overexpression model. Behavioral neuroscience 122, 491-497, doi:10.1037/0735-7044.122.3.491 (2008).
30. Ishii, M., Wang, G., Racchumi, G., Dyke, J. P. & Iadecola, C. Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 9096-9106, doi:10.1523/ jneurosci.0872-14.2014 (2014).
31. Toledo, J. B. et al. Cardiovascular risk factors, cortisol, and amyloid-beta deposition in Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & dementia: the journal of the Alzheimer's Association 8, 483-489, doi:10.1016/j.jalz.2011.08.008 (2012).
32. Kaplan, R. J., Greenwood, C. E., Winocur, G. & Wolever, T. M. Cognitive performance is associated with glucose regulation in healthy elderly persons and can be enhanced with glucose and dietary carbohydrates. The American journal of clinical nutrition 72, 825-836 (2000).
33. Sabia, S., Kivimaki, M., Shipley, M. J., Marmot, M. G. & Singh-Manoux, A. Body mass index over the adult life course and cognition in late midlife: the Whitehall II Cohort Study. The American journal of clinical nutrition 89, 601-607, doi:10.3945/ajcn.2008.26482 (2009).
34. Yaffe, K. et al. The metabolic syndrome, inflammation, and risk of cognitive decline. Jama 292, 2237-2242, doi:10.1001/ jama.292.18.2237 (2004).
35. Bettcher, B. M. et al. Body mass and white matter integrity: the influence of vascular and inflammatory markers. PloS one 8, e77741, doi:10.1371/journal.pone.0077741 (2013).